Skip to main content
Equibles

Stratos Wealth Partners, LTD.

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1612865 BEACHWOOD, OH
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,850,720
+$2,048,160 QoQ
Shares Held
408,000
0.0% QoQ
Ownership
0.687%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#25
of 158 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Stratos Wealth Partners, LTD. holds $14,445,280 across 20 Biotechnology names. ZVRA ranks #1 (40.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZVRA
Zevra Therapeutics, Inc.
This page 		408,000 $5,850,720
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,267 $1,622,816
3 PLX
Protalix BioTherapeutics, Inc.
 500,000 $1,165,000
4 PHAT
Phathom Pharmaceuticals, Inc.
 100,000 $1,085,000
5 IONS
Ionis Pharmaceuticals Inc
 7,801 $618,541
6 KRYS
Krystal Biotech, Inc.
 1,382 $513,647
7 BBIO
BridgeBio Pharma, Inc.
 6,603 $491,791
8 GANX
Gain Therapeutics, Inc.
 200,000 $406,000

All Filings in ZVRA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,850,720 408,000
2026-03-31 $3,802,560 408,000
2025-12-31 $3,664,640 409,000
2025-09-30 $2,177,790 229,000
2025-06-30 $1,938,200 220,000
2025-03-31 $2,321,900 310,000
2024-12-31 $2,800,905 335,840
2024-09-30 $2,905,361 418,640
2024-06-30 $344,176 70,240
2024-03-31 $407,392 70,240
2023-12-31 $460,072 70,240
2023-09-30 $338,364 70,200
2023-06-30 $358,020 70,200
2023-03-31 $386,100 70,200
2022-12-31 $322,218 70,200
2022-09-30 $438,048 70,200
2022-06-30 $314,684 70,557
2022-03-31 $354,952 70,567
2021-12-31 $625,874 71,857
2021-09-30 $662,028 70,957